Cargando…

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

BACKGROUND: Benzodiazepine (BZD) misuse is a significant public health problem, particularly in conjunction with opioid use, due to increased risks of overdose and death. One putative mechanism underlying BZD misuse is affective dysregulation, via exaggerated negative affect (e.g., anxiety, depressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenwald, Mark K., Moses, Tabitha E. H., Lundahl, Leslie H., Roehrs, Timothy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892948/ https://www.ncbi.nlm.nih.gov/pubmed/36741122 http://dx.doi.org/10.3389/fpsyt.2023.1103739

Ejemplares similares

Training medical students in opioid overdose prevention and response: Comparison of In-Person versus online formats
por: Moses, Tabitha E. H., et al.
Publicado: (2021)

Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
por: Smith, Mark A., et al.
Publicado: (2022)

Co-prescription of opioids with benzodiazepine and other co-medications among opioid users: differential in opioid doses
por: Zin, Che Suraya, et al.
Publicado: (2017)

Addiction, Anhedonia, and Comorbid Mood Disorder. A Narrative Review
por: Destoop, Marianne, et al.
Publicado: (2019)

The four-factor personality model and its qualitative correlates among opioid agonist therapy clients
por: Mahu, Ioan T., et al.
Publicado: (2023)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone
por: Mallik, Adiel, et al.
Publicado: (2017)

Forging Neuroimaging Targets for Recovery in Opioid Use Disorder
por: Stewart, Jennifer L., et al.
Publicado: (2019)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Chronic neuropathic pain reduces opioid receptor availability with associated anhedonia in rat
por: Thompson, Scott J., et al.
Publicado: (2018)

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
por: Noble, Florence, et al.
Publicado: (2019)

Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse
por: Strickland, Justin C., et al.
Publicado: (2022)

Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program
por: Moses, Tabitha E, et al.
Publicado: (2022)

Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions
por: Delorme, Jessica, et al.
Publicado: (2018)

Novel Synthetic Opioids (NSO) Use in Opioid Dependents Entering Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2022)

The Accessibility of Opioid Agonist Treatment and Its Forced Discontinuation in Swiss Prisons—Attitudes, Perceptions and Experiences of Defense Lawyers in Dealing With Detained Persons Using Opioids
por: Buadze, Anna, et al.
Publicado: (2020)

An Effective and Safe Novel Treatment of Opioid Use Disorder: Unilateral Transcranial Photobiomodulation
por: Schiffer, Fredric, et al.
Publicado: (2021)

Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
por: Kakko, Johan, et al.
Publicado: (2019)

A Systematic Review of Opioid Use Disorder and Related Biomarkers
por: Bryant, Bianca M., et al.
Publicado: (2021)

The Heterogeneity of Empathy: Possible Treatment for Anhedonia?
por: Light, Sharee N.
Publicado: (2019)

A Transdiagnostic Perspective on Social Anhedonia
por: Barkus, Emma, et al.
Publicado: (2019)

Accessibility of Treatment Among Women With Opioid Use Disorder: A Brief Review
por: Khan, Abdul Rahim, et al.
Publicado: (2022)

The growing problem of co-treatment with opioids and benzodiazepines
por: Karaca-Mandic, Pinar, et al.
Publicado: (2017)

A comparison of opioids and benzodiazepines dispensing in Australia
por: Islam, M. Mofizul, et al.
Publicado: (2019)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
por: Sanger, Nitika, et al.
Publicado: (2020)

MicroRNA–mRNA networks are dysregulated in opioid use disorder postmortem brain: Further evidence for opioid-induced neurovascular alterations
por: Grimm, Sandra L., et al.
Publicado: (2023)

Operational definition of precipitated opioid withdrawal
por: Dunn, Kelly E., et al.
Publicado: (2023)

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023)

Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression
por: Ely, Benjamin A., et al.
Publicado: (2021)

Opioid and benzodiazepine prescribing after COVID‐19 hospitalization
por: Delaney, Lia D., et al.
Publicado: (2022)

Acute Psychotic Episode Precipitated by Opioid Withdrawal in a Case of Bipolar I Disorder
por: Shah, Darshini B, et al.
Publicado: (2023)

Cognitive Biases in Cannabis, Opioid, and Stimulant Disorders: A Systematic Review
por: Zhang, Melvyn W. B., et al.
Publicado: (2018)

Trends of Opioid Use Disorder and Associated Factors in Hospitalized Patients With Arthritis
por: Oladunjoye, Adeolu O, et al.
Publicado: (2020)

Commentary: Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice
por: Zheng, Rui, et al.
Publicado: (2021)

Synthetic cannabinoids use in a sample of opioid-use disorder patients
por: Alías-Ferri, María, et al.
Publicado: (2022)

Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
por: Yu, Lingfang, et al.
Publicado: (2021)

Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?
por: Houeto, Jean-Luc, et al.
Publicado: (2016)

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
por: von Bernuth, Kira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_om9s6gnvfkkofbp490hodcdocm